Category Archives: Coronary Heart Diseases

Millions of people in the UK and around the world spend many years of their later life in poor health. Our Future Health aims to tackle this and help people live healthier lives for longer by creating the UKs largest ever health research programme to prevent, detect and treat diseases Continue reading →

JAMA Netw Open. 2022 Mar 1;5(3):e223849. Continue reading →

The new report by Expert Market Research titled, Global Heparin Market Size, Share, Price, Trends, Growth, Report and Forecast 2021-2026, gives an in-depth analysis of the globalheparin market, assessing the market based on its segments like application, route of administration, end-use, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market Continue reading →

AWANS, Belgium, March 29, 2022 /PRNewswire/ -- Miracor Medical SA (Miracor Medical) today announced the first patient enrolled in the PICSO-AMI-V study to evaluate the benefits of PiCSO (Pressure Controlled Intermittent Coronary Sinus Occlusion) therapy as an adjunct to conventional primary percutaneous coronary intervention (PCI) for patients presenting with inferior ST-Elevation Myocardial Infarction (STEMI). "Improving outcomes for patients with large heart attacks remains an important unmet need." The first patient enrolled was treated at the University Hospital of Toulouse, France by the team of Professor Didier Carri (Drs T Continue reading →

Three companies have posted major developments in the field of heart disease therapy. AstraZeneca, Moderna AZD8601 Drug Trial Meets Primary Endpoint AstraZenecaandModernatoday announced that its drug candidate for the treatment of patients with heart failure met its primary endpoint of safety and tolerability. In thePhase IIA EPICCURE trial, scientists injected AZD8601, an mRNA encoding vascular endothelial growth factor (VEGF-A), into the myocardium of patients undergoing elective coronary artery bypass (CABG) surgery Continue reading →

Are coronary heart diseases on the rise among below poverty line (BPL) families in Karnataka? A study by researchers of the University of Mysore says the diseases are indeed increasing and the worrying trend needs to be studied in detail, finding out reasons for the rise and helping families prevent them. The study was done by the Centre for Study of Social Exclusion and Inclusive Policy (CSSEIP) based on the 10-year data sourced from the Karnataka Suvarna Suraksha Arogya Trust (R), Bengaluru. Continue reading →

The NHS explains that the chest can feel like it's being pressed or squeezed by a heavy object. Complications of a heart attack can be serious and possibly life threatening, so if you have signs get emergency help Continue reading →

DUBLIN, Nov. 12, 2021 /PRNewswire/ -- The "Cardiovascular Stent Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. Research and Markets Logo The global cardiovascular stent market is calculated to escalate at a CAGR of 7.18% during the forecast period to reach US$15.594 billion by 2026, from US$9.597 billion in 2019 Continue reading →

Researchers from Harvard T.H. Chan School of Public Health led a large-scale study of over 10,000 adults to determine the link between consumption of sodium and potassium with cardiovascular risk. The research combined high-quality data of individuals from six cohort studies where sodium is measured by multiple 24-hour urine samples. Continue reading →

Before COVID-19 shut down the world in the Spring of 2020, the thought was that this latest virus was primarily a disease of the respiratory system. As the virus became widespread, hospitals started to fill up with COVID-positive patients whose symptoms manifested in many physiological forms. Continue reading →